FDA to ease copycat drug rules, speeding access to cheaper drugs

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...
MarketBeat on MSN

ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat

AbbVie Inc. (NYSE: ABBV) delivered a strong third-quarter earnings report with a beat on the top and bottom lines and an ...